← All organizations
Opko
For profitWebsite ↗
Also known as: Associate Director Clinical Affairs OPKO Biologics | EIRGEN | Epigenetix, Inc. | ModeX Therapeutics, An OPKO Health Company | Opko Biologics | OPKO Health | OPKO Health, Inc. | Opko Health Spain, S.L.U. | OPKO IP Holdings II, Inc. | OPKO IRELAND GLOBAL | OPKO Ireland Global Holdings Ltd. | Opko Renal | OPKO Renal | SVP at Opko Health
Highest phase reached
Phase 4
Timeline
1990s
- Jul 1, 1991
Opko— Founded
2010s
- Jun 17, 2016
calcifediol— Marketing Organization
- Jun 17, 2016
calcifediol— NDA Secondary Org
- Jun 30, 2016
Transition Therapeutics— Acquired
Drugs by trial phase (36 distinct, 51 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (6 own, 7 via acquisition)
Phase 1 (4 own, 5 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Bone Neoplasms
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dwarfism, Pituitary
- Edema
- Endocrine System Diseases
- Hemophilia A
- Hemophilia B
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
- Hypocalcemia
- Kidney Diseases
- Kidney Failure, Chronic
- Macular Degeneration
- Macular Edema
- Neoplasm Metastasis
- Obesity
- Prostatic Neoplasms
- Psoriasis
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Vitamin D Deficiency
Marketed drugs (3)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT07249905Lead sponsorPhase 1/Phase 2Mar 31, 2026
- NCT07110584Lead sponsorPhase 1/Phase 2Oct 1, 2025
- NCT06239194Lead sponsorPhase 1/Phase 2Jun 12, 2024
- NCT05543928Lead sponsorPhase 3Dec 31, 2022
- NCT05543928Study directorPhase 3Dec 31, 2022
- NCT05488548Lead sponsorPhase 1Sep 30, 2022
- NCT04551911Lead sponsorPhase 2Oct 26, 2020
- NCT04551911Study directorPhase 2Oct 26, 2020
- NCT03810664Lead sponsorPhase 1Jan 18, 2019
- NCT03660800Lead sponsorPhase 1Aug 20, 2018
- NCT03602261Lead sponsorPhase 2Jul 9, 2018
- NCT03588884Lead sponsorPhase 4Jun 8, 2018
- NCT03406377Lead sponsorPhase 2Apr 2, 2018
- NCT03406377CollaboratorPhase 2Apr 2, 2018
- NCT03874013Lead sponsorPhase 3Dec 7, 2017
Details
- Founded
- Miami, FL, US Jul 1, 1991
- Last known activity
- Mar 31, 2026